发明授权
- 专利标题: Oxadiazolyl intermediates
- 专利标题(中): 恶二唑基中间体
-
申请号: US942200申请日: 1986-12-16
-
公开(公告)号: US4727153A公开(公告)日: 1988-02-23
- 发明人: Frank Watjen , Mogens Engelstoft
- 申请人: Frank Watjen , Mogens Engelstoft
- 申请人地址: DKX Soborg
- 专利权人: A/S Ferrosan
- 当前专利权人: A/S Ferrosan
- 当前专利权人地址: DKX Soborg
- 优先权: DKX1080/85 19850308; DKX1081/85 19850308; DKX2203/85 19850517; DKX2204/85 19850517; DKX4769/85 19851017
- 主分类号: C07D
- IPC分类号: C07D20060101 ; C07D271/06 ; C07D487/04 ; C07D487/14
摘要:
New oxadiazolyl imidazobenzodiazepine derivatives having the formula ##STR1## wherein R.sup.3 has the formula ##STR2## wherein R" is hydrogen, C.sub.1-6 alkyl C.sub.1-6 alkoxymethyl or C.sub.3-6 -cycloalkyl;R.sup.4 is hydrogen;R.sup.5 is C.sub.1-6 alkyl or R.sup.4 and R.sup.5 together form a 2-4 membered alkylene bridge; and R.sup.A is C.sub.1-6 alkyl, C.sub.1-6 alkoxy, or C.sub.1-3 trifluoroalkyl, pharmaceutical compositions thereof, and method of treating therewith, are disclosed.The compounds and pharmaceutical compositions are useful in the amelioration, mitigation, or elimination of central nervous system disorders related to benzodiazepine receptors and especially as anticonvulsants, anxiolytics, hypnotics, and nootropics.
公开/授权文献
信息查询